Article
High frequency of bedaquiline resistance in programmatically treated drug-resistant TB patients with sustained culture-positivity in Cape Town, South Africa
2022-11-14
Abstract excerpt
<h4>Introduction</h4> Bedaquiline (BDQ) is a lifesaving new tuberculosis (TB) drug undergoing global scale-up. Data on resistance emergence in programmatic settings, especially in patients resistant to other drugs with potentially weak background regimens, is scarce. Such individuals are a priority for novel drug access yet a potential source of population-level resistance. <h4>Methods</h4> We collected culture is...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 31f1ed1a-2136-56b4-a2d2-0760d74dbd11
- DOI
- 10.1101/2022.11.14.22282167
